Author

Beate Lungerich

Heinrich Heine University Düsseldorf

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Thomas KurziD· 2 shared André HaaseiD· 1 shared André Schultz· 1 shared Annabelle Friedrich· 1 shared Arndt BorkhardtiD· 1 shared Björn B. Burckhardt· 1 shared Björn StorkiD· 1 shared Céline David· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Thomas KurzORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

3-Hydroxypropanamidines: from antiplasmodial leads to a novel antibacterial scaffold

Lara-Sophie Kaufmann, André Schultz, Noemi Wladarz, Tanja Gangnus, Beate Lungerich, Tanja C. Knaab, André Haase, Lea Joswig, Finn Dressler, Pascal Dietze, Ralf A. Benndorf, Björn B. Burckhardt, Thomas Kurz, Julia Elisabeth Bandow

This study evaluates the antibacterial activity and properties of three 3-hydroxypropanamidines against Gram-positive and Gram-negative bacteria.

bioRxiv · Sep 21, 2026 · PreprintMicrobiology

Small-molecule inhibitor of C-terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells

Céline David, Yadong Sun, Vitalij Woloschin, Melina Vogt, Niklas Dienstbier, Annabelle Friedrich, Karina Stephanie Krings, David Schlütermann, Lena Berning, Beate Lungerich, Seda Akgün, María José Mendiburo, Christoph G. W. Gertzen, Arndt Borkhardt, Sebastian Wesselborg, , Björn Stork

This paper introduces a C-terminal HSP90 dimerization inhibitor, VWK147, which induces cell death in cisplatin-resistant cancer cells and synergizes with mTOR inhibition to enhance therapeutic efficacy.

Cell Death and Disease · Dec 23, 2025Peer-reviewedCell Biology